Detalhe da pesquisa
1.
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
Cancer Immunol Immunother
; 69(5): 703-716, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034426
2.
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 168(2): 559-566, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247442
3.
Emerging PARP inhibitors for treating breast cancer.
Expert Opin Emerg Drugs
; 23(3): 211-221, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30251552
4.
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Eur J Cancer
; 202: 114034, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537315
5.
Evaluating everolimus for the treatment of breast cancer.
Expert Opin Pharmacother
; 24(10): 1105-1111, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183684
6.
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.
Neuro Oncol
; 25(3): 495-507, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953421
7.
Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.
Sci Rep
; 11(1): 22057, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34764361
8.
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-ß and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.
Neurooncol Adv
; 3(1): vdab058, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056607
9.
Pertuzumab for the treatment of breast cancer.
Expert Rev Anticancer Ther
; 20(2): 85-95, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30884986
10.
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer.
Expert Opin Drug Metab Toxicol
; 15(2): 85-91, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30577708
11.
Benefits versus risk profile of buparlisib for the treatment of breast cancer.
Expert Opin Drug Saf
; 18(7): 553-562, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31159599
12.
[Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores]. / Essais de phase précoce à l'Institut de cancérologie de l'Ouest : réponse au traitement et validation de scores pronostiques.
Bull Cancer
; 105(10): 896-906, 2018 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-30348261
13.
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer.
Drugs
; 78(13): 1353-1362, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30143968
14.
Efficacy of buparlisib in treating breast cancer.
Expert Opin Pharmacother
; 18(18): 2007-2016, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169282
15.
Olaparib for the treatment of breast cancer.
Expert Opin Investig Drugs
; 26(6): 751-759, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28395540
16.
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy.
Ther Adv Med Oncol
; 9(5): 335-346, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529550
17.
Vinflunine for the treatment of breast cancer.
Expert Opin Pharmacother
; 17(13): 1817-23, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27484180
18.
What is the best choice of partner chemotherapy with trastuzumab for metastatic breast cancer?
Expert Rev Anticancer Ther
; 12(2): 195-201, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22316367
19.
Eribulin mesylate for the treatment of late-stage breast cancer.
Expert Opin Pharmacother
; 12(18): 2883-90, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22087618